WO1997041850A1 - Paclitaxel for the treatment of rheumatic diseases - Google Patents
Paclitaxel for the treatment of rheumatic diseases Download PDFInfo
- Publication number
- WO1997041850A1 WO1997041850A1 PCT/KR1996/000183 KR9600183W WO9741850A1 WO 1997041850 A1 WO1997041850 A1 WO 1997041850A1 KR 9600183 W KR9600183 W KR 9600183W WO 9741850 A1 WO9741850 A1 WO 9741850A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- paclitaxel
- treatment
- mice
- disease
- rheumatic diseases
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU73413/96A AU7341396A (en) | 1996-05-02 | 1996-10-26 | Paclitaxel for the treatment of rheumatic diseases |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1996/14189 | 1996-05-02 | ||
KR1019960014189A KR100191446B1 (ko) | 1996-05-02 | 1996-05-02 | 파클리탁셀 함유 전신성 홍반성 낭창치료제 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997041850A1 true WO1997041850A1 (en) | 1997-11-13 |
Family
ID=19457526
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR1996/000183 WO1997041850A1 (en) | 1996-05-02 | 1996-10-26 | Paclitaxel for the treatment of rheumatic diseases |
Country Status (3)
Country | Link |
---|---|
KR (1) | KR100191446B1 (ko) |
AU (1) | AU7341396A (ko) |
WO (1) | WO1997041850A1 (ko) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993000928A1 (fr) * | 1991-07-08 | 1993-01-21 | Rhone-Poulenc Rorer S.A. | Nouvelles compositions a base de derives de la classe des taxanes |
WO1994012198A1 (en) * | 1992-11-27 | 1994-06-09 | F.H. Faulding & Co. Limited | Injectable taxol composition |
WO1994012172A1 (en) * | 1992-12-02 | 1994-06-09 | Thomas Jefferson University | Methods of killing protozoal parasites |
WO1994012171A1 (fr) * | 1992-12-02 | 1994-06-09 | Rhone-Poulenc Rorer S.A. | Compositions injectables a base de derives des taxanes |
-
1996
- 1996-05-02 KR KR1019960014189A patent/KR100191446B1/ko not_active IP Right Cessation
- 1996-10-26 AU AU73413/96A patent/AU7341396A/en not_active Abandoned
- 1996-10-26 WO PCT/KR1996/000183 patent/WO1997041850A1/en active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1993000928A1 (fr) * | 1991-07-08 | 1993-01-21 | Rhone-Poulenc Rorer S.A. | Nouvelles compositions a base de derives de la classe des taxanes |
WO1994012198A1 (en) * | 1992-11-27 | 1994-06-09 | F.H. Faulding & Co. Limited | Injectable taxol composition |
WO1994012172A1 (en) * | 1992-12-02 | 1994-06-09 | Thomas Jefferson University | Methods of killing protozoal parasites |
WO1994012171A1 (fr) * | 1992-12-02 | 1994-06-09 | Rhone-Poulenc Rorer S.A. | Compositions injectables a base de derives des taxanes |
Non-Patent Citations (3)
Title |
---|
ARTHRITIS & RHEUMATISM, June 1994, Volume 37, No. 36, BRAHN E. et al., "Regression of Collagen-Induced Arthritis with Taxol, a Microtubule Stabilizer", pp. 839-845. * |
CELLULAR IMMUNOLOGY, August 1994, Volume 157, No. 1, OLIVER S.J. et al., "Suppression of Collagen-Induced Arthritis Using an Angiogenesis Inhibitor, AGM-1470 and a Microtubule Stabilizer, Taxol", pp. 291-299. * |
CHEMICAL ABSTRACTS, Vol. 106, No. 22, 01 June 1987, (Columbus, Ohio, USA), page 405, Abstract No. 182581c, B.D. TARR et al., "A New Parenteral Vehicle for the Administration of Some Poorly Water Soluble Anti-Cancer Drugs"; & J. PARENTER. SCI. TECHNOl., 41(1), 31-3, (ENG). * |
Also Published As
Publication number | Publication date |
---|---|
AU7341396A (en) | 1997-11-26 |
KR970073582A (ko) | 1997-12-10 |
KR100191446B1 (ko) | 1999-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Akhtari et al. | Neutropenia in a patient treated with ipilimumab (anti–CTLA-4 antibody) | |
Asgeirsdottir et al. | Site-specific inhibition of glomerulonephritis progression by targeted delivery of dexamethasone to glomerular endothelium | |
US20130022609A1 (en) | Method of treating androgen independent prostate cancer | |
Drach et al. | Induction of differentiation in myeloid leukemia cell lines and acute promyelocytic leukemia cells by liposomal all-trans-retinoic acid | |
RU2472526C2 (ru) | Фармацевтическая композиция, содержащая анти-cd6 моноклональное антитело, пригодная для диагностики и лечения ревматоидного артрита | |
CZ111595A3 (cs) | Dithiokarbamáty pro ošetřování aterosklerózy a jiných kardiovaskulátních a zánětlivých chorob | |
Gelsomino et al. | Programmed death-1 inhibition and atherosclerosis: can nivolumab vanish complicated atheromatous plaques? | |
RU2177316C2 (ru) | Фармацевтическая композиция для лечения рака и вирусных заболеваний, способ лечения рака, способ лечения вирусных инфекций на ее основе | |
CN117771364A (zh) | 基于抗cd47剂的卵巢癌疗法 | |
EA006314B1 (ru) | Способ ингибирования прогрессивного развития или стабилизации волчаночного нефрита | |
JP2005538093A (ja) | 抗血管形成療法のための、テトラポリアンモニウムテトラチオモリブデートおよび関連化合物 | |
KR19990036138A (ko) | 암 성장을 억제하기 위한 플루코나졸의 용도 | |
SK14098A3 (en) | Use of 1h-1,2,4-triazole derivatives for inhibiting the growth of cancers | |
EP3765090A1 (en) | Combination of cd47 blockade therapy and a cd38 antibody | |
Collins et al. | The anticancer drug, cisplatin, increases the naturally occurring cell-mediated lysis of tumor cells | |
Song et al. | A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA/1J mice | |
Foster et al. | Serum concentration measurements in man of the radiosensitizer Ro-07-0582: some preliminary results. | |
Asako et al. | Phalloidin prevents leukocyte emigration induced by proinflammatory stimuli in rat mesentery | |
KR20160087037A (ko) | 혈관석회화 방지용 조성물 및 이를 포함하는 혈관 석회화 치료제 | |
WO2008157369A2 (en) | Use of taci-ig fusion protein such as atacicept for the manufacture of a medicament for treating lupus erythematosus | |
WO1997041850A1 (en) | Paclitaxel for the treatment of rheumatic diseases | |
US6972175B2 (en) | Inhibition of Egr-1 expression by ppar-gamma agonists and related compositions and methods | |
US20070231317A1 (en) | S100 Protein Inhibitors for Treating Leukemia | |
KR20080000682A (ko) | 17-aag 또는 17-ag, 또는 이들의 프로드럭을 사용한다발성 골수종의 치료 방법 | |
EP4065599A1 (en) | Compositions and methods for treating diseases and conditions by depletion of mitochondrial or genomic dna from circulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA CN HU JP MX US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97539755 Format of ref document f/p: F |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |